[144] Hims & Hers Health, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Hims & Hers Health, Inc. (HIMS) reports proposed and recent sales of Class A common stock by insiders and related parties. The filing lists a proposed sale of 47,534 shares via Fidelity (approximate market value $2,141,494) with an approximate sale date of 08/18/2025 on the NYSE. It shows acquisition details for 46,534 vested restricted shares received in 2022 and 2023 as compensation. The filing also discloses multiple completed insider sales between 06/16/2025 and 07/21/2025 totaling several hundred thousand shares and gross proceeds in the multi‑million dollar range. The filer certifies they are not aware of undisclosed material adverse information.

Positive

• Regulatory compliance: The filer submitted a Form 144 disclosing proposed and recent insider sales, fulfilling Rule 144 reporting obligations
• Acquisition transparency: The filing specifies that the sold shares were primarily received via restricted stock vesting, with exact vesting dates and amounts

Negative

• Insider selling activity: Multiple substantial sales occurred between 06/16/2025 and 07/21/2025, generating multi‑million dollar gross proceeds, which increases share supply
• Concentration of disposals: Sales by one individual and a related trust over a short period may raise investor concerns about insider liquidity or sentiment

Insights

Securities Analyst

TL;DR: Multiple insider sales and a pending sale were disclosed, signaling insider liquidity but formally filed under Rule 144.

The filing documents a proposed sale of 47,534 Class A shares (~$2.14M) and details recent executed sales on specific dates between June and July 2025 that generated multi‑million dollar proceeds. Acquisition history shows these shares primarily arose from restricted stock vesting in 2022 and 2023 as compensation. From a market perspective, these are clear insider dispositions that increase share supply; the filing itself fulfills regulatory disclosure obligations but does not include management commentary or reasons for sales.

Corporate Governance Expert

TL;DR: The filing is a routine compliance disclosure, but clustered insider sales merit attention for governance review.

The notice confirms reliance on Rule 144 procedures for planned dispositions and includes the signers representation about lack of undisclosed material information. The pattern of several large sales by an individual and a related trust over a short period could prompt questions about succession of trading plans or liquidity needs; however, the document contains no assertions about 10b5-1 plans or strategic rationale, so governance implications are observational rather than evidentiary.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	47534	2141494.49	217641958	08/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/15/2022	Restricted Stock Vesting	Issuer			2899	09/15/2022	Compensation
Class A	12/15/2022	Restricted Stock Vesting	Issuer			35366	12/15/2022	Compensation
Class A	03/15/2023	Restricted Stock Vesting	Issuer			9269	03/15/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Andrew Dudum 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/16/2025	128127	7230644.74
Dudum Family Community Property Trust Dtd 03/04/21 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/16/2025	47534	2686298.76
Andrew Dudum 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/17/2025	65110	3855543.59
Andrew Dudum 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/16/2025	2792	141216.51
Dudum Family Community Property Trust Dtd 03/04/21 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/16/2025	47534	2388816.19
Andrew Dudum 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/21/2025	125335	6208636.66

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing say about HIMS insider sales?

The filing discloses a proposed sale of 47,534 Class A shares (approx. $2,141,494) for 08/18/2025 and lists multiple completed sales between 06/16/2025 and 07/21/2025 that produced multi‑million dollar gross proceeds.

Who sold HIMS shares according to the filing?

The sellers named include Andrew Dudum and the Dudum Family Community Property Trust, with addresses and amounts detailed for each sale.

How were the sold shares acquired according to the filing?

Acquisition entries show the shares were primarily received through restricted stock vesting on 09/15/2022, 12/15/2022, and 03/15/2023 as compensation.

Does the filing state whether a 10b5-1 trading plan was used?

The filing includes a signature representation about material information but does not indicate a plan adoption date or explicitly confirm reliance on a 10b5-1 trading plan.

On which exchange were the proposed shares to be sold?

The proposed sale is listed to occur on the NYSE via Fidelity Brokerage Services LLC.